•
Dec 31, 2021

NeueHealth Q4 2021 Earnings Report

Reported fourth quarter and full year 2021 financial results.

Key Takeaways

Bright Health Group reported a Q4 2021 revenue of $962.3 million, a 167.5% increase year-over-year. However, the company experienced a GAAP Net Loss of $813.4 million and an Adjusted EBITDA loss of $790.1 million.

Achieved substantial growth in 2021, delivering $4 billion in Revenue.

Reached a significant scale milestone of serving over 1 million health plan lives for the start of 2022.

Experienced challenges during the year which resulted in worse than expected performance.

Focused on driving results off our scaled platform in 2022 and beyond.

Total Revenue
$962M
Previous year: $360M
+167.5%
EPS
-$103
Previous year: -$96
+7.5%
Medical Cost Ratio
134.1%
Previous year: 105.4%
+27.2%
Operating Cost Ratio
47.7%
Previous year: 41.3%
+15.5%
Gross Profit
$962M
Previous year: $360M
+167.5%
Cash and Equivalents
$289M
Previous year: $488M
-40.8%
Free Cash Flow
-$161M
Previous year: -$73.9M
+117.7%
Total Assets
$3.6B
Previous year: $1.81B
+98.7%

NeueHealth

NeueHealth

NeueHealth Revenue by Segment

Forward Guidance

For full year 2022, Bright Health Group expects a revenue of $6.8 to $7.1 billion and an adjusted EBITDA loss of $500 to $800 million.

Positive Outlook

  • Bright Health Group’s total Revenue is expected to be $6.8 billion to $7.1 billion
  • Enterprise Medical Cost Ratio between 90% and 94%.
  • Bright HealthCare end-of-year membership is expected to be approximately 1,000,000
  • NeueHealth Revenue is expected to be approximately $2.3 billion.
  • Intercompany Revenue elimination is expected to be approximately $1.2 to $1.4 billion.

Challenges Ahead

  • Adjusted EBITDA for 2022 is expected to be a loss of between $500.0 and $800.0 million

Revenue & Expenses

Visualization of income flow from segment revenue to net income